Nice value, EbiT margin rising, profit and sales rising, P/E falling to 12 which is attractive, 2026 PEG of 0.6 is also good, 126m market value is really small, so I would perhaps like to see a little more growth. Chartwise also very nice, but should face a small correction.
@Tenbagger2024 I think the valuation is excellent. The company is now taking the next step. Locations are already represented worldwide, AI and robots are on the rise, and there is nothing more suitable than software development in the healthcare sector. Sales growth is great. IPO is planned for Thursday. Just skimmed the annual report for 2024. Top.
